The safety of any drug needs to be well established to ensure the safety of the consumer. NBI’s oral insulin has been established to be safe through in vitro cytotoxicity studies in Caco-2 and HeLa cells. The NBI strategic innovation team brough in Dr Sandeep Jain, Dr Madhukar Saxena and Dr Amit Pal.